A method for the treatment of epilepsy comprising the administration of a potassium channel activator, such as (-)-6-cyano-3,4-dihydro-2,2-dimethyl-trans-4- (2-oxo-1-pyrrolidinyl)-2H-benzo¢b!pyran-3-ol.
TREATMENT